Market Overview
The global retinitis pigmentosa (RP) treatment market is experiencing growth driven by rare disease focus, therapeutic development, and patient population needs. The retinitis pigmentosa market is projected to exceed USD 4.8 billion through 2030, fueled by affected patients exceeding 2 million globally, disease understanding advancement, and treatment pipeline expansion....
0 Commentarios
0 Acciones
231 Views
0 Vista previa
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek